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Zerumbone significantly improved immunoreactivity in the synovium compared to 
Channa striatus extract in monosodium iodoacetate (MIA)-induced knee osteoarthritis 
in rat. 
ABSTRACT 
The main aim of this study was to compare the immunoreactivity of some osteoarthritis 
related neuropeptides following oral administration of two natural remedies that is Channa 
striatus extract and zerumbone against monosodium iodoacetate induced knee osteoarthritis 
changes in the rat’s synovial membrane. Assay of PGE2 and PGF2α in the serum were 
performed to evaluate their role during osteoarthritis events and post oral application of the 
treatment. Forty rats were divided equally into four groups. Rats in the first and second 
groups were received channa extract and zerumbone, respectively. Rats in the third group 
were treated with celecoxib, whereas the fourth group was treated with normal saline. 
Evaluation of immunoreactivity of the following neuropeptides: Protein gene product 9.5, 
calcitonin gene related peptide and neuropeptide Y in the synovial membranes was 
implemented with the aid of both histopathology and immunohistochemistry approaches. 
Results revealed lower pathology score in both first and second groups accompanied with 
markedly improved immunoreactivity in zerumbone treated groups compared to channa 
extract group. Significant different concentrations of PGE2 but not PGF2α were detected 
within studied groups. Both remedies significantly improved the immunoreactivity which 
appeared more apparent in the group treated with zerumbone. Prostaglandin E2 has a role in 
osteoarthritis development and regulation.  
  
Keyword: Channa striatus; Osteoarthritis; Neuropeptides; Zerumbone; Monosodium 
iodoacetate; Rat. 
 
